Search

everythinglearnresearchcommunity

for

Search:↓

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Testosterone's muscle-building effects do not require its conversion to DHT.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Citrullus colocynthis fruit extract may effectively treat testosterone-related hair loss, similar to finasteride.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

The lotion with specific plant extracts effectively increased hair growth and improved hair cycle in subjects after 3 months.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Testosterone helps human pancreatic cells increase insulin release.